Overview

Oligonucleotide Synthesis Market is anticipated to value over CAGR of over 16.4% during the forecast period 2022 to 2028.

Oligonucleotide synthesis deals with the compounding of short fragments of nucleic acid with a specific sequence. Genetic research has a wide scope and has multiple categories of the study. Oligonucleotide synthesis one of the integral sectors in genetics. The variety of clinical and diagnostic applications of oligonucleotide synthesis have fostered the market growth and is positively influencing the CAGR.

Currently, advancements in oligonucleotide synthesizers are the key elements in driving the market. The automated synthesizers that are able to synthesize up to hundreds of DNA/oligo sequences simultaneously are currently trending. The reduced time and expenses along with less volume of samples are expected to be the key features responsible for increasing the market share globally.

The fluorescence in situ hybridization (FISH) and PCR primers are major applications of oligonucleotide synthesis. FISH is an integral part of the microbiology industry. Detection, visualization and identification of genetic disorders, microbial culture, etc. has been made easy by FISH. This has stimulated the demand and growth of the market.

The growing interest of the pharma industry towards genetic research is a major driver for the market. Currently, most of the pharma companies are investing in genetically engineered products because of their variable applications and preference by healthcare experts. Hence, the pharmaceutical industry is anticipated to have a notable growth in the market of oligonucleotide synthesis.

The focus on genetic research and the promotive expenditure has made North America one of the dominating regions in the market. The interest in the genetic sector and a favourable research environment are positive factors for the research growth in North America. Moreover, the Asia Pacific region is anticipated to have a major market share as many government and non-government organizations tend to promote and raise funds for the research in the genetics field.

Major players included in the Oligonucleotide Synthesis Market:
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• LGC Limited
• Maravai Life Sciences
• Agilent Technologies, Inc.
• Biogen Inc.
• Sarepta Therapeutics, Inc.
• Eurofins Scientific
• Kaneka Corporation
• Biolytic Lab Performance Inc.
• Microsynth Ag
(Note: The list of the major players will be updated with the latest market scenario and trends

Oligonucleotide Synthesis Market Segmentation:

By Product
• Oligonucleotide-based Drugs
• Synthesized Oligonucleotides
• By Product
o Primers
o Probes
o DNA Oligos
o RNA Oligos
o Other Synthesized Oligos
• By Type
o Customized Oligos
o Predesigned Oligos
• Reagents
• Equipment

By Application
• Research Applications
o PCR
o Sequencing
o Other Research Applications
• Diagnostic Applications

By Type
• Antisense Oligonucleotide-based Therapies
• RNAi Oligonucleotide-based Therapies
• CpG Oligonucleotide-based Therapies

By Disease Type
• Neurological Disorders
• Infectious Diseases
• Other Diseases

By End User
• Hospitals
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• CROs and CMOs
• Academic Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Oligonucleotide Synthesis Market By Product, By Application, By Type, By Disease Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com